Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

ARSENICAL DRUGS.

. ' MAY POISON BODY WHILE KILLING DISEASE GERMS. /j(By T«lefr*ph-Pres« A«*n.-Copyright.) (Australian Press Assp, and Sun.) (Efeccived This Day, 12.55 p.m.) LONDON, February 28. Following, up Dr. Colobrook 'a and OaptainlS. E, Douglas’s wat tmie in-, of the 'drugi aalvarsan and being- of use in the treatment of septicemia, Dr. Colebrooke lately extended investigations to puerpural infection. The Medical Research Council publishes his report, which takes -into account the possibility of a 'chemo-therapeutic agent defeating its own ends by con.currenfc poisoning of body cells. Summing up, the report says; “ Although there .is ground , for believing the administration of these arsenical -drugs sometimes leads to the destruction -of streptococci and assists patients to , this should not be expected in all cases. Therefore it is necessary that careful clinical tests be carried out to determine precisely how much can '.be achieved.’’ .

Permanent link to this item

https://paperspast.natlib.govt.nz/newspapers/LDC19280229.2.27

Bibliographic details

Levin Daily Chronicle, 29 February 1928, Page 5

Word Count
140

ARSENICAL DRUGS. Levin Daily Chronicle, 29 February 1928, Page 5

ARSENICAL DRUGS. Levin Daily Chronicle, 29 February 1928, Page 5

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert